Transcriptional Profiling Identifies Altered Intracellular Labile Iron Homeostasis as a Contributing Factor to the Toxicity of Adaphostin: Decreased Vascular Endothelial Growth Factor Secretion Is Independent of Hypoxia-Inducible Factor-1 Regulation
暂无分享,去创建一个
E. Sausville | A. Monks | C. Hose | G. Kaur | G. Kaur
[1] G. Minotti,et al. Doxorubicin Paradoxically Protects Cardiomyocytes against Iron-mediated Toxicity , 2004, Journal of Biological Chemistry.
[2] K. Jungermann,et al. A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[3] K. Pantopoulos. Iron Metabolism and the IRE/IRP Regulatory System: An Update , 2004, Annals of the New York Academy of Sciences.
[4] E. Sausville,et al. Induction of apoptosis in human leukemia cells by the tyrosine kinase inhibitor adaphostin proceeds through a RAF-1/MEK/ERK- and AKT-dependent process , 2004, Oncogene.
[5] Y. Pommier,et al. Topoisomerase I-Mediated Inhibition of Hypoxia-Inducible Factor 1 , 2004, Cancer Research.
[6] E. Sausville,et al. Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells. , 2003, Blood.
[7] E. Sausville,et al. In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines , 2002, Cancer Chemotherapy and Pharmacology.
[8] D. Scudiero,et al. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. , 2002, Cancer research.
[9] J. Joseph,et al. Transferrin Receptor-dependent Iron Uptake Is Responsible for Doxorubicin-mediated Apoptosis in Endothelial Cells , 2002, The Journal of Biological Chemistry.
[10] A. Urbano,et al. Mechanisms of apoptosis by the tyrphostin AG957 in hematopoietic cells. , 2002, Biochemical pharmacology.
[11] E. Sausville,et al. Effects of the Bcr/abl kinase inhibitors STI571 and adaphostin (NSC 680410) on chronic myelogenous leukemia cells in vitro. , 2002, Blood.
[12] P. Sharma,et al. Release of iron from ferritin by metabolites of benzene and superoxide radical generating agents. , 2001, Toxicology.
[13] A. Harris,et al. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[14] G. Semenza. HIF-1 and mechanisms of hypoxia sensing. , 2001, Current opinion in cell biology.
[15] Elizabeth C. Theil,et al. Combinatorial mRNA Regulation: Iron Regulatory Proteins and Iso-iron-responsive Elements (Iso-IREs)* , 2000, The Journal of Biological Chemistry.
[16] A. Harris,et al. Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. , 2000, Cancer research.
[17] F. Petrat,et al. Determination of the chelatable iron pool of single intact cells by laser scanning microscopy. , 2000, Archives of biochemistry and biophysics.
[18] R. Eisenstein. Iron regulatory proteins and the molecular control of mammalian iron metabolism. , 2000, Annual review of nutrition.
[19] E. Sausville,et al. Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[20] C. Beaumont,et al. H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. , 1999, Blood.
[21] M. Buchwald,et al. Loss of FancC Function Results in Decreased Hematopoietic Stem Cell Repopulating Ability , 1999, Blood.
[22] E. Sausville,et al. Different early effets of tyrphostin AG957 and geldanamycins on mitogen-activated protein kinase and p120cbl phosphorylation in anti CD-3-stimulated T-lymphoblasts. , 1999, Biochemical pharmacology.
[23] R. Bhatia,et al. Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores β1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors , 1998, Leukemia.
[24] C. Beaumont,et al. Role of Ferritin in the Control of the Labile Iron Pool in Murine Erythroleukemia Cells* , 1998, The Journal of Biological Chemistry.
[25] E. Sausville,et al. Altered physical state of p21bcr—abl in tyrphostin AG957-treated K562 cells , 1996, Anti-cancer drugs.
[26] J. Folkman,et al. Fighting cancer by attacking its blood supply. , 1996, Scientific American.
[27] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[28] M. Hentze,et al. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[29] G. Semenza,et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[30] E. Sausville,et al. Tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemia. , 1994, Anti-cancer drugs.
[31] Georg Breier,et al. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.
[32] Elizabeth C. Theil. Regulation of ferritin and transferrin receptor mRNAs. , 1990, The Journal of biological chemistry.
[33] D A Scudiero,et al. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. , 1989, Journal of the National Cancer Institute.
[34] D. Hanahan,et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.